Abstract
Background A 3-month-old male infant presented, beginning on the second day of life, with paroxysmal painful events that started with tonic contraction of the whole body followed by erythematous harlequin-type color changes.
Investigations Screening of the SCN9A gene, which encodes the voltage-gated sodium channel NaV1.7, identified a new mutation, Gly1607Arg, located within the domain IV S4 voltage sensor. Whole-cell patch-clamp analysis demonstrated functional effects of the mutant channel that included impaired inactivation—a hallmark of paroxysmal extreme pain disorder (PEPD).
Diagnosis The patient was diagnosed as having PEPD, an autosomal dominant disorder characterized by severe rectal pain triggered by defecation or perineal stimulation, usually followed by ocular or submaxillary pain. Erythematous flushing, sometimes in a harlequin pattern, can be a prominent feature of this condition.
Management Treatment with carbamazepine (10 mg/kg/day) for ≈3 months was ineffective in this case, and the parents made a decision to discontinue the drug. The mother was instructed to avoid painful stimuli that could trigger an episode.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Dib-Hajj, S. D. et al. Paroxysmal extreme pain disorder M1627K mutation in human Nav1.7 renders DRG neurons hyperexcitable. Mol. Pain 4, 37 (2008).
Fertleman, C. R. et al. Paroxysmal extreme pain disorder (previously familial rectal pain syndrome). Neurology 69, 586–595 (2007).
Estacion, M. et al. NaV1.7 gain-of-function mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders. J. Neurosci. 28, 11079–11088 (2008).
Hayden, R. & Grossman, M. Rectal, ocular, and submaxillary pain, a familial autonomic disorder related to proctalgia fugax: report of a family. Am. J. Dis. Child. 97, 479–482 (1959).
Dugan, R. E. Familial rectal pain. Lancet 1, 854 (1972).
Fertleman, C. R. & Ferrie C. D. What's in a name—familial rectal pain syndrome becomes paroxysmal extreme pain disorder. J. Neurol. Neurosurg. Psychiatry 77, 1294–1295 (2006).
Djouhri, L. et al. Sensory and electrophysiological properties of guinea-pig sensory neurones expressing Nav1.7 (PN1) Na+ channel α subunit protein. J. Physiol. 546, 565–576 (2003).
Toledo-Aral, J. J. et al. Identification of PN1, a predominant voltage dependent sodium channel expressed principally in peripheral neurons. Proc. Natl Acad. Sci. USA 94, 1527–1532 (1997).
Rush, A. M. et al. A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. Proc. Natl Acad. Sci. USA 103, 8245–8250 (2006).
Fertleman, C. R. et al. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 52, 767–774 (2006).
Jarecki, B. W., Sheets, P. L. & Jackson, J. O. Paroxysmal extreme pain disorder mutations within the D3/S4–S5 linker of Nav1.7 cause moderate destabilization of fast inactivation. J. Physiol. 586, 4137–4153 (2008).
Crill, W. Persistent sodium current in mammalian central neurons. Annu. Rev. Physiol. 58, 349–362 (1996).
Cheng, X. et al. Mutations at opposite ends of the DIII/S4–S5 linker of sodium channel NaV1.7 produce distinct pain disorders. Mol. Pain 6, 24 (2010).
Drenth, J. P. H. & Waxman, S. G. Mutations in sodium channel gene SCN9A cause a spectrum of human genetic pain disorders. J. Clin. Invest. 177, 3603–3609 (2007).
Dib-Hajj, S. D., Cummins, T. R., Black, J. A. & Waxman, S. G. Sodium channels in normal and pathological pain. Annu. Rev. Neurosci. 33, 325–347 (2010).
Choi, J. S. et al. Mexiletine-responsive erythromelalgia due to a new Nav1.7 mutation showing use-dependent current fall-off. Exp. Neurol. 16, 383–389 (2009).
Fischer, T. Z. et al. A novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgia. Ann. Neurol. 65, 733–741 (2009).
Williams, B. S. et al. Characterization of a new class of potent inhibitors of the voltage-gated sodium channel Nav1.7. Biochemistry 46, 14693–14703 (2007).
Acknowledgements
Written consent for publication was obtained from the patient's parents. We are grateful to Dr Caroline Espil-Taris for help in the diagnosis and treatment of our patient, and to Lynda Tyrrell for technical assistance. This work was supported in part by the Rehabilitation Research Service and Medical Research Service, Department of Veterans Affairs, and the Erythromelalgia Association. The Center for Neuroscience and Regeneration Research is a Collaboration of the Paralyzed Veterans of America and United Spinal Association with Yale University.
Author information
Authors and Affiliations
Contributions
J.-S. Choi, F. Boralevi, J. P. H. Drenth and S. G. Waxman researched data for the article and contributed to discussion of content, writing, and review and editing of the manuscript before submission. O. Brissaud researched data and contributed to discussion of content, review and editing of the manuscript. J. Sánchez-Martín researched data and contributed to the writing of the article. R. H. M. te Morsche researched data and contributed to review and editing of the manuscript. S. D. Dib-Hajj contributed to discussion of content, writing, and review and editing of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Choi, JS., Boralevi, F., Brissaud, O. et al. Paroxysmal extreme pain disorder: a molecular lesion of peripheral neurons. Nat Rev Neurol 7, 51–55 (2011). https://doi.org/10.1038/nrneurol.2010.162
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2010.162
This article is cited by
-
A novel SCN9A gene variant identified in a Chinese girl with paroxysmal extreme pain disorder (PEPD): a rare case report
BMC Medical Genomics (2022)
-
Hydropathicity-based prediction of pain-causing NaV1.7 variants
BMC Bioinformatics (2021)
-
Inhibition of Nav1.7 channel by a novel blocker QLS-81 for alleviation of neuropathic pain
Acta Pharmacologica Sinica (2021)
-
Paroxysmal extreme pain disorder in family with c.3892G > T (p.Val1298Phe) in the SCN9A gene mutation – case report
BMC Neurology (2020)
-
Computational pipeline to probe NaV1.7 gain-of-function variants in neuropathic painful syndromes
Scientific Reports (2020)